Identification of small molecule inhibitors of G3BP-driven stress granule formation
Journal of Cell Biology · 04.03.2024 · 223 (3)
DOI: 10.1083/jcb.202308083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, online erschienen am 29.01.2024. Verfasst von Brian D Freibaum und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Hauptthemen laut MEDLINE: DNA Helicases, RNA Helicases, Stress Granules. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Stress granule formation is triggered by the release of mRNAs from polysomes and is promoted by the action of the RNA-binding proteins G3BP1/2. Stress granules have been implicated in several disease states, including cancer and neurodegeneration. Consequently, compounds that limit stress granule formation or promote their dissolution have potential as both experimental tools and novel therapeutics. Herein, we describe two small molecules, G3BP inhibitor a and b (G3Ia and G3Ib), designed to bind to a specific pocket in G3BP1/2 that is targeted by viral inhibitors of G3BP1/2 function. In addition to disrupting the co-condensation of RNA, G3BP1, and caprin 1 in vitro, these compounds inhibit stress granule formation in cells treated prior to or concurrent with stress and dissolve pre-existing stress granules. These effects are consistent across multiple cell types and a variety of initiating stressors. Thus, these compounds represent powerful tools to probe the biology of stress granules and hold promise for therapeutic interventions designed to modulate stress granule formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
- Faze Medicines , Cambridge, MA, USA.
- Department of Biochemistry, University of Colorado, Boulder, CO, USA.
- Howard Hughes Medical Institute, Chevy Chase, MD, USA.
ORCID-Profile: Brian D Freibaum, James Messing, Haruko Nakamura, Ugur Yurtsever, Jinjun Wu, Hong Joo Kim, Jeff Hixon, Rene Marc Lemieux, Jay Duffner, Walter Huynh, Kathy Wong, Michael White, Christina Lee, Rachel E Meyers, Roy Parker, J Paul Taylor
Förderung
- NINDS NIH HHS
- NIH HHS
- Howard Hughes Medical Institute
- National Institutes of Health
Zitieren
APA
Freibaum, B. D., Messing, J., Nakamura, H., Yurtsever, U., Wu, J., Kim, H. J., Hixon, J., Lemieux, R. M., Duffner, J., Huynh, W., Wong, K., White, M., Lee, C., Meyers, R. E., Parker, R., & Taylor, J. P. (2024). Identification of small molecule inhibitors of G3BP-driven stress granule formation. Journal of Cell Biology, 223(3). https://doi.org/10.1083/jcb.202308083
Vancouver
Freibaum BD, Messing J, Nakamura H, Yurtsever U, Wu J, Kim HJ, et al. Identification of small molecule inhibitors of G3BP-driven stress granule formation. Journal of Cell Biology. 2024;223(3). doi:10.1083/jcb.202308083
BibTeX
@article{Freibaum2024,
author = {Freibaum, Brian D and Messing, James and Nakamura, Haruko and Yurtsever, Ugur and Wu, Jinjun and Kim, Hong Joo and Hixon, Jeff and Lemieux, Rene Marc and Duffner, Jay and Huynh, Walter and Wong, Kathy and White, Michael and Lee, Christina and Meyers, Rachel E and Parker, Roy and Taylor, J Paul},
title = {Identification of small molecule inhibitors of G3BP-driven stress granule formation},
journal = {Journal of Cell Biology},
year = {2024},
volume = {223},
number = {3},
doi = {10.1083/jcb.202308083}
}
EUVIMED